文献速递系统性红斑狼疮

I型干扰素通过脱落白细胞介素-6受体限制系统性红斑狼疮中的白细胞介素-6信号传导

Type I interferon limits interleukin-6 signalling in SLE through shedding interleukin-6 receptors.
PubMed 文献 · Rheumatology (Oxford) · 2025-01-01

研究比较SLE患者与健康个体的血清和外周血单个核细胞,发现IL-6与I型干扰素联合诱导淋巴细胞CD126脱落为可溶性IL-6受体(sIL-6R),使IL-6信号转向反式信号传导,并减少IL-6刺激后的STAT3磷酸化。该机制解释了活动性SLE中CRP仅轻度升高而合并细菌感染时CRP升高的矛盾现象。

要点

  • SLE活动性升高时sIL-6R与IL-6升高,但CD126阳性淋巴细胞减少。
  • IL-6联合IFNα使淋巴细胞CD126下降、上清sIL-6R升高。
  • IL-6刺激后STAT3磷酸化减少,IL-6信号转向反式信号传导。

核心结论

  • IL-6与I型干扰素联合诱导CD126脱落为sIL-6R,使IL-6信号转向反式信号传导。
  • 仅在IL-6超过sIL-6R的情况下,IL-6或IL-6-sIL-6R复合物到达肝脏并升高CRP。

研究设计与样本

  • 研究检测SLE患者与健康个体的血清和外周血单个核细胞,用ELISA测IL-6和sIL-6R,用流式细胞术分析膜IL-6受体α(CD126)、gp130(CD130)及IL-6刺激后STAT3磷酸化。
  • 用多种细胞因子刺激外周血单个核细胞和HepG2肝细胞,通过免疫沉淀和蛋白质印迹检测上清中IL-6受体脱落。
  • 将HEK-293T细胞转染野生型CD126或脱落抵抗突变体,检测细胞因子刺激后的可溶性sIL-6R。

主要发现

  • sIL-6R和IL-6随SLE活动性升高,而CD126阳性淋巴细胞在SLE中减少。
  • IL-6联合IFNα使淋巴细胞CD126下降、上清sIL-6R升高,免疫沉淀和蛋白质印迹可检测到。
  • IL-6联合IFNα作用于HepG2肝细胞也导致类似的sIL-6R升高。
  • 转染野生型CD126的HEK-293T细胞上清sIL-6R升高,转染脱落抵抗突变体的细胞则无此升高。
  • IL-6刺激后STAT3磷酸化减少。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To fully understand why C-reactive protein (CRP) is usually only mildly elevated in active systemic lupus erythematosus (SLE), although interleukin-6 (IL-6) is increased, but is high in SLE patients with bacterial infections. METHODS: Sera and peripheral blood mononuclear cells (PBMCs) of SLE patients and healthy individuals were investigated. IL-6 and soluble IL-6 receptor (sIL-6R) were measured by ELISA. Membrane IL-6 receptor-α (CD126), gp130 (CD130) and signal transducer and activator of transcription 3 (STAT3) phosphorylation after IL-6 stimulation were analysed by flow cytometry. PBMCs and HepG2 liver cells were stimulated with various cytokines, and IL-6 receptor shedding was determined by immunoprecipitation and western blotting of supernatants. HEK-293 T cells were transfected with wild type CD126 or a shedding-resistant mutant, and soluble sIL-6R was measured following cytokine stimulation. RESULTS: While sIL-6R and IL-6 were increased with SLE activity, CD126 positive lymphocytes were decreased in SLE. IL-6 plus IFNα decreased CD126 on lymphocytes, but increased sIL-6R in their supernatant, detected by immunoprecipitation and western blotting. IL-6 plus IFNα on HepG2 liver cells resulted in a similar sIL-6R increase. Increased supernatant sIL-6R was seen in HEK-293 T cells transfected with wild type CD126, but not those transfected with the shedding-resistant mutant. STAT3 phosphorylation upon IL-6 stimulation was reduced. CONCLUSION: The combination of IL-6 and type I IFN induces shedding of CD126 to sIL-6R, shifting IL-6 signalling to trans-signalling. In situations of IL-6 excess over sIL-6R only, IL-6 or IL-6-sIL-6R complexes reach the liver and increase CRP. These findings not only explain the discrepancy in SLE, but also have implications for severe viral infection.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Hempel M, Klapproth E, Krause A, et al. Type I interferon limits interleukin-6 signalling in SLE through shedding interleukin-6 receptors. Rheumatology (Oxford). 2025. PMID: 40632603. doi:10.1093/rheumatology/keaf281

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。